Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Evotec AG Operating Expenses 2010-2024 | EVO

Evotec AG operating expenses from 2010 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
  
Evotec AG Annual Operating Expenses
(Millions of US $)
2023 $897
2022 $770
2021 $683
2020 $517
2019 $430
2018 $352
2017 $249
2016 $147
2015 $129
2014 $116
2013 $109
2012 $108
2011 $104
2010 $36
2009 $87
Evotec AG Quarterly Operating Expenses
(Millions of US $)
2024-09-30 $232
2024-06-30 $309
2024-03-31 $246
2023-09-30 $227
2023-06-30 $225
2022-12-31 $209
2022-09-30 $189
2022-06-30 $187
2022-03-31 $184
2021-12-31 $198
2021-09-30 $167
2021-06-30 $165
2021-03-31 $152
2020-12-31 $151
2020-09-30 $132
2020-06-30 $120
2020-03-31 $114
2019-12-31 $121
2019-09-30 $102
2019-06-30 $110
2019-03-31 $96
2018-12-31 $100
2018-09-30 $68
2018-06-30 $95
2018-03-31 $89
2017-12-31 $86
2017-09-30 $70
2017-06-30 $49
2017-03-31 $43
2016-12-31 $35
2016-09-30 $37
2016-06-30 $37
2016-03-31 $38
2015-12-31 $24
2015-09-30 $38
2015-06-30 $39
2015-03-31 $28
2014-12-31 $28
2014-09-30 $28
2014-06-30 $31
2014-03-31 $29
2013-12-31 $28
2013-09-30 $27
2013-06-30 $28
2013-03-31 $26
2012-12-31 $29
2012-09-30 $26
2012-06-30 $25
2012-03-31 $28
2011-12-31 $32
2011-09-30 $26
2011-06-30 $24
2011-03-31 $22
2010-12-31 $15
2010-09-30 $17
2010-06-30 $17
2010-03-31 $16
2009-12-31 $18
2009-09-30 $20
2009-06-30 $23
2009-03-31 $27
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.506B $0.846B
EVOTEC is a leader in the discovery and development of novel small molecule drugs. They have established a powerful platform that is applicable to targets across all therapeutic areas and has specific expertise in the area of Central Nervous System related diseases where it is building a pipeline of drug candidates for partnering. Through research collaborations and proprietary projects They are providing the highest quality research results to its partners in the pharmaceutical and biotechnology industries
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $78.616B 30.25
Takeda Pharmaceutical (TAK) Japan $44.101B 9.18
Merck (MKKGY) Germany $21.176B 23.11
Astellas Pharma (ALPMY) Japan $20.449B 18.83
Sandoz Group AG (SDZNY) Switzerland $19.727B 0.00
United Therapeutics (UTHR) United States $17.973B 17.68
Summit Therapeutics (SMMT) United States $15.560B 0.00
Neurocrine Biosciences (NBIX) United States $12.553B 33.24
Shionogi (SGIOY) Japan $12.508B 11.98
Catalent (CTLT) United States $10.876B 0.00
Madrigal Pharmaceuticals (MDGL) United States $7.739B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.354B 7.04
Orion OYJ (ORINY) Finland $6.848B 19.25
Ionis Pharmaceuticals (IONS) United States $6.073B 0.00
Corcept Therapeutics (CORT) United States $5.689B 43.10
Crinetics Pharmaceuticals (CRNX) United States $4.787B 0.00
PTC Therapeutics (PTCT) United States $3.305B 0.00
Dyne Therapeutics (DYN) United States $2.939B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.773B 12.57
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.665B 15.38
Arrowhead Pharmaceuticals (ARWR) United States $2.659B 0.00
Soleno Therapeutics (SLNO) United States $2.462B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.038B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.948B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.829B 0.00
Harrow (HROW) United States $1.771B 0.00
Ocular Therapeutix (OCUL) United States $1.681B 0.00
Xencor (XNCR) United States $1.622B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.589B 0.00
ARS Pharmaceuticals (SPRY) United States $1.565B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.513B 0.00
Ardelyx (ARDX) United States $1.511B 0.00
Indivior (INDV) United States $1.492B 6.08
Enliven Therapeutics (ELVN) United States $1.370B 0.00
Guardian Pharmacy Services (GRDN) United States $1.304B 0.00
Cassava Sciences (SAVA) United States $1.216B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.193B 0.00
Collegium Pharmaceutical (COLL) United States $1.118B 6.11
Bioventus (BVS) United States $0.910B 28.82
Relay Therapeutics (RLAY) United States $0.822B 0.00
Cronos Group (CRON) Canada $0.788B 0.00
USANA Health Sciences (USNA) United States $0.772B 14.32
Ironwood Pharmaceuticals (IRWD) United States $0.744B 0.00
Tourmaline Bio (TRML) United States $0.709B 0.00
Savara (SVRA) United States $0.662B 0.00
Korro Bio (KRRO) United States $0.643B 0.00
Exscientia (EXAI) United Kingdom $0.638B 0.00
Larimar Therapeutics (LRMR) United States $0.582B 0.00
ProKidney (PROK) United States $0.559B 0.00
Siga Technologies (SIGA) United States $0.545B 6.36
Verve Therapeutics (VERV) United States $0.538B 0.00
OmniAb (OABI) United States $0.535B 0.00
Elite Pharmaceuticals (ELTP) United States $0.534B 49.99
Silence Therapeutics (SLN) United Kingdom $0.533B 0.00
Altimmune (ALT) United States $0.530B 0.00
Xeris Biopharma Holdings (XERS) United States $0.501B 0.00
KalVista Pharmaceuticals (KALV) United States $0.483B 0.00
Zevra Therapeutics (ZVRA) United States $0.464B 0.00
Aquestive Therapeutics (AQST) United States $0.463B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.445B 0.00
Organogenesis (ORGO) United States $0.432B 0.00
4D Molecular Therapeutics (FDMT) United States $0.430B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.428B 0.00
Esperion Therapeutics (ESPR) United States $0.414B 0.00
Akebia Therapeutics (AKBA) United States $0.392B 0.00
Sage Therapeutics (SAGE) United States $0.387B 0.00
Avita Medical (RCEL) United States $0.322B 0.00
Aldeyra Therapeutics (ALDX) United States $0.317B 0.00
Lyell Immunopharma (LYEL) United States $0.312B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.272B 110.29
Heron Therapeutics (HRTX) United States $0.268B 0.00
Acrivon Therapeutics (ACRV) United States $0.263B 0.00
Lexeo Therapeutics (LXEO) United States $0.261B 0.00
Nature's Sunshine Products (NATR) United States $0.257B 15.23
Nektar Therapeutics (NKTR) United States $0.252B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.240B 0.00
Pyxis Oncology (PYXS) United States $0.234B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.223B 0.00
Profound Medical (PROF) Canada $0.221B 0.00
Nanobiotix S.A (NBTX) France $0.203B 0.00
MediWound (MDWD) Israel $0.181B 0.00
Innate Pharma SA (IPHYF) France $0.180B 0.00
Galectin Therapeutics (GALT) United States $0.177B 0.00
Aclaris Therapeutics (ACRS) United States $0.175B 0.00
Achieve Life Sciences (ACHV) Canada $0.172B 0.00
Cardiol Therapeutics (CRDL) Canada $0.165B 0.00
Context Therapeutics (CNTX) United States $0.157B 0.00
Incannex Healthcare (IXHL) Australia $0.154B 0.00
CytoDyn (CYDY) United States $0.152B 0.00
VAXART, INC (VXRT) United States $0.128B 0.00
Century Therapeutics (IPSC) United States $0.124B 0.00
Telomir Pharmaceuticals (TELO) United States $0.124B 0.00
Journey Medical (DERM) United States $0.118B 0.00
OptiNose (OPTN) United States $0.116B 0.00
Fractyl Health (GUTS) United States $0.116B 0.00
AlloVir (ALVR) United States $0.113B 0.00
Karyopharm Therapeutics (KPTI) United States $0.111B 0.00
Relmada Therapeutics (RLMD) United States $0.098B 0.00
Regulus Therapeutics (RGLS) United States $0.097B 0.00
Assertio Holdings (ASRT) United States $0.096B 16.83
PMV Pharmaceuticals (PMVP) United States $0.092B 0.00
Arch Biopartners (ACHFF) Canada $0.091B 0.00
CASI Pharmaceuticals (CASI) China $0.087B 0.00
ElectroCore (ECOR) United States $0.082B 0.00
ESSA Pharma (EPIX) Canada $0.079B 0.00
Metagenomi (MGX) United States $0.076B 0.00
Swiftmerge Acquisition (IVCP) United States $0.076B 368.67
Prelude Therapeutics (PRLD) United States $0.070B 0.00
Vivani Medical (VANI) United States $0.070B 0.00
Citius Pharmaceuticals (CTXR) United States $0.069B 0.00
Inotiv (NOTV) United States $0.068B 0.00
Nutriband (NTRB) United States $0.062B 0.00
Champions Oncology (CSBR) United States $0.059B 0.00
Mural Oncology (MURA) Ireland $0.058B 0.00
Gain Therapeutics (GANX) United States $0.057B 0.00
Qilian Holding Group (BGM) China $0.055B 0.00
Unicycive Therapeutics (UNCY) United States $0.054B 0.00
Protara Therapeutics (TARA) United States $0.052B 0.00
SCYNEXIS (SCYX) United States $0.050B 0.00
Rafael Holdings (RFL) United States $0.047B 0.00
VYNE Therapeutics (VYNE) United States $0.047B 0.00
Carisma Therapeutics (CARM) United States $0.043B 0.00
DURECT (DRRX) United States $0.042B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.038B 0.00
BioLineRx (BLRX) Israel $0.036B 0.00
Surrozen (SRZN) United States $0.033B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.032B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.031B 0.00
FibroGen (FGEN) United States $0.031B 0.00
Oruka Therapeutics (ORKA) United States $0.031B 0.00
Lipocine (LPCN) United States $0.030B 0.00
Iterum Therapeutics (ITRM) Ireland $0.030B 0.00
Natural Alternatives (NAII) United States $0.028B 0.00
ProPhase Labs (PRPH) United States $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.027B 0.00
GlycoMimetics (GLYC) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.027B 0.00
BioVie (BIVI) United States $0.025B 0.00
Inhibikase Therapeutics (IKT) United States $0.021B 0.00
MEI Pharma (MEIP) United States $0.020B 0.70
Marinus Pharmaceuticals (MRNS) United States $0.020B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.019B 0.00
TherapeuticsMD (TXMD) United States $0.018B 0.00
Lyra Therapeutics (LYRA) United States $0.017B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.017B 0.00
PolyPid (PYPD) Israel $0.016B 0.00
Minerva Neurosciences (NERV) United States $0.016B 0.00
Cosmos Health (COSM) United States $0.016B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.016B 0.00
Talphera (TLPH) United States $0.015B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
NRx Pharmaceuticals (NRXP) United States $0.014B 0.00
Nuvilex (PMCB) United States $0.014B 0.00
Vivos Therapeutics (VVOS) United States $0.014B 0.00
Avalo Therapeutics (AVTX) United States $0.013B 0.00
Indaptus Therapeutics (INDP) United States $0.012B 0.00
Addex Therapeutics (ADXN) Switzerland $0.011B 0.00
CERo Therapeutics Holdings (CERO) United States $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.011B 0.00
Dominari Holdings (DOMH) United States $0.011B 0.00
Redhill Biopharma (RDHL) Israel $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Conduit Pharmaceuticals (CDT) United States $0.009B 0.00
Jaguar Animal Health (JAGX) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.008B 0.00
Viracta Therapeutics (VIRX) United States $0.007B 0.00
Klotho Neurosciences (KLTO) United States $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Biomerica (BMRA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Oncternal Therapeutics (ONCT) United States $0.004B 0.00
Ainos (AIMD) United States $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
TNF Pharmaceuticals (TNFA) United States $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.09
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Molecular Templates (MTEM) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 3.21
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 44.55